Skip to content
buyWeak cluster of 2

Sean Ellis bought $12k of ENTX

director at Entera Bio Ltd.. 10,000 shares at an average of $1.23, traded Mar 5, 2026, filed Mar 9, 2026.

Conviction score
39
Value
$12k
10,000 shares
Holdings after
188,098
+6% from before
From 52-week low
+18%
low $1.04, close $1.23
From 52-week high
-61%
high $3.14, as of Mar 5, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $12k at market
    0
  • Relative to holdings
    Holdings up 6%
    +3
  • Price context
    61% below the 52-week high
    +8
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -12.0%, 3m -9.8%, 6m +125.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ENTXOct 13, 2026 · close 2.49
Since filing Mar 9, 2026: +87.2%SPY +15.6% · excess +71.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001178913-26-000787, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 5, 2026POpen-market purchase
Ordinary Shares, par value NIS 0.0000769 per share
+10,000$1.23$12k188,098Mar 9, 2026

Related signals

Other insiders at Entera Bio Ltd. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
51Moderate
ENTXbuy 2
Entera Bio Ltd.
Geno J Germano
director
$26k
20,000 shares
+100%
53Moderate
ENTXbuy 4
Entera Bio Ltd.
Steven D Rubin
director
$7,450
5,000 shares
+50%
41Moderate
ENTXbuy 4
Entera Bio Ltd.
Sean Ellis
director
$22k
18,000 shares
+11%
46Moderate
ENTXbuy 4
Entera Bio Ltd.
Steven D Rubin
director
$12k
10,000 shares
-
43Moderate
ENTXbuy 4
Entera Bio Ltd.
Geno J Germano
director
$30k
20,000 shares
-
38Weak
ENTXbuy 4
Entera Bio Ltd.
Haya Taitel
director
$11k
7,500 shares
-
25Weak
ENTXbuy
Entera Bio Ltd.
Miranda Jayne Toledano
Chief Executive Officer
$20k
11,000 shares
+3%
30Weak
ENTXbuy
Entera Bio Ltd.
Haya Taitel
director
$9,405
9,500 shares
+37%
29Weak
ENTXbuy
Entera Bio Ltd.
Haya Taitel
director
$5,864
7,615 shares
+42%
47Moderate
ENTXbuy 2
Entera Bio Ltd.
Miranda Jayne Toledano
Chief Executive Officer
$17k
23,952 shares
+28%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Sean Ellis bought $12k of ENTX | InsiderTell